首页> 美国卫生研究院文献>Scientific Reports >Majority of Chinese Medicine Herb Category Qing Re Yao Have Multiple Mechanisms of Anti-inflammatory Activity
【2h】

Majority of Chinese Medicine Herb Category Qing Re Yao Have Multiple Mechanisms of Anti-inflammatory Activity

机译:大多数中草药清热药具有多种抗炎活性的机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Herbs categorized as “Qing Re Yao” are translated into “medicine that removes heat” where heat symptoms strongly resemble inflammation. 226 herbs, among those 54 herbs are classified as “Qing Re Yao”, were studied on six key mechanisms of inflammation: COX2, iNOS activity, and the pathways of IL-6, IFNγ, TNF-α and glucocorticoid in order to assess if the majority of this family of herbs have anti-inflammatory activity. 96% demonstrated at least one anti-inflammatory process or innate immunity modular activity, and 72% could affect one anti-inflammatory process. Of the, 54 “Qing Re Yao” 68% affect at least 2 mechanism compared to only 4% (47 herbs) in the “Bu Yi Yao” category that are used to “tonify body energy” and prevent diseases. Moreover 43% of “Qing Re Yao” herbs affect 3 or more mechanisms while none of the “Bu Yi Yao” have this poly-mechanism quality. Additionally “Qing Re Yao” herbs exhibiting activity against STAT3 or GAS could have downstream effects on these target genes and their pathways. Our study addresses the key action on why “Qing Re Yao” work on inflammation. This study also demonstrates the utility in isolating anti-inflammatory substances to be used as a lead for drug discovery and development.
机译:被归类为“清热药”的草药被翻译为“清热药”,其中热症状非常类似于炎症。研究了54种被归类为“清热药”的226种草药,研究了其六个主要炎症机制:COX2,iNOS活性以及IL-6,IFNγ,TNF-α和糖皮质激素的途径,以评估是否该草药家族中的大多数具有抗炎活性。 96%的人表现出至少一种抗炎过程或先天性免疫模块活性,而72%的人可能影响一种抗炎过程。其中54种“清热药”中有68%影响至少两种机理,而“补衣药”类别中只有4%(47种草药)用于“补体”和预防疾病。此外,有43%的“清热腰”草药会影响3种或更多的机制,而“补腰腰”中没有一种具有这种多机制的质量。此外,对STAT3或GAS表现出活性的“清热药”草药可能会对这些靶基因及其途径产生下游影响。我们的研究针对“清热要药”为何能治疗炎症的关键作用。这项研究还证明了在分离抗炎物质中的用途,该物质可用作药物发现和开发的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号